Suppr超能文献

相似文献

2
Interval approach to assessing antitumor activity for tumor xenograft studies.
Pharm Stat. 2010 Jan-Mar;9(1):46-54. doi: 10.1002/pst.369.
3
Statistical inference for tumor growth inhibition T/C ratio.
J Biopharm Stat. 2010 Sep;20(5):954-64. doi: 10.1080/10543401003618983.
4
Assessing cytotoxic treatment effects in preclinical tumor xenograft models.
J Biopharm Stat. 2009 Sep;19(5):755-62. doi: 10.1080/10543400903105158.
5
Assessment of antitumor activity for tumor xenograft studies using exponential growth models.
J Biopharm Stat. 2011 May;21(3):472-83. doi: 10.1080/10543406.2010.481802.
6
A simulation-based sample size calculation method for pre-clinical tumor xenograft experiments.
J Biopharm Stat. 2018;28(3):437-450. doi: 10.1080/10543406.2017.1315820. Epub 2017 Apr 27.
7
Modeling sustained treatment effects in tumor xenograft experiments.
J Biopharm Stat. 2014;24(4):755-67. doi: 10.1080/10543406.2014.901340.
10
Confidence interval estimation of the common mean of several gamma populations.
PLoS One. 2022 Jun 17;17(6):e0269971. doi: 10.1371/journal.pone.0269971. eCollection 2022.

本文引用的文献

1
The pediatric preclinical testing program: description of models and early testing results.
Pediatr Blood Cancer. 2007 Dec;49(7):928-40. doi: 10.1002/pbc.21078.
2
Interval estimates for the ratio and difference of two lognormal means.
Stat Med. 2006 Dec 15;25(23):4099-113. doi: 10.1002/sim.2504.
3
Smooth quantile ratio estimation with regression: estimating medical expenditures for smoking-attributable diseases.
Biostatistics. 2005 Oct;6(4):505-19. doi: 10.1093/biostatistics/kxi031. Epub 2005 May 4.
4
Discovery and preclinical antitumor efficacy evaluations of LY32262 and LY33169.
Invest New Drugs. 2003 Feb;21(1):33-45. doi: 10.1023/a:1022912208877.
5
Likelihood analysis for the ratio of means of two independent log-normal distributions.
Biometrics. 2002 Jun;58(2):463-9. doi: 10.1111/j.0006-341x.2002.00463.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验